Clinical Research Directory

Inclusion Criteria: * Woman * Age 40-70 years * Any form of UI - stress incontinence (AI), urge incontinence (TI) or mixed urinary incontinence (MUI) according to QUID * No major language difficulties that prevent understanding and speaking the Swedish language and filling in questionnaires. Exclusion Criteria: * Woman with a serious illness such as psychosis, pulmonary insufficiency, epilepsy, severe depression, dementia, is being treated in palliative care, has ongoing drug or alcohol abuse * Implanted pacemaker or larger metal implant in the body: metal plates, screws, defibrillator and metal implants in the pelvic area or copper coil * The patient has a piercing between the waist and knees and is not willing to remove it before each treatment * Pregnant, or planning to become pregnant, at screening or at any time during the study period * Painful urges * Bladder emptying difficulties * Previous malignancy in the abdomen or urinary tract * Pelvic floor physical therapy, including muscle training and/or electrical stimulation, in a clinical setting within 30 days prior to screening * Severely overweight (defined as weight \> 135 kg) * Pulmonary insufficiency, defined as difficulty breathing and fatigue, especially during exercise * Any condition that causes a lack of normal skin sensation in the pelvis, buttocks and lower extremities * Currently recovering from surgical procedures where muscle contraction may interfere with the healing process * Currently receiving treatment for a malignant tumor that would interfere with study participation. * Used the BTL EMSELLA unit before * The person has urinary incontinence of neurogenic etiology, such as multiple sclerosis, spina bifida, Parkinson's, spinal cord injury, diabetic neuropathy, etc. * Vaginal prolapse * Vaginal rejuvenation treatment, including laser treatments and radiofrequency therapy, within 6 months prior to the screening visit